Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bonifazi (Ancona (AN), Italy), N. Sverzellati (Parma (PR) , Italy), E. Negri (Milano (MI), Italy), J. Jacob (London , United Kingdom), R. Egashira (Saga, Japan), S. Piciucchi (Forlì, Italy), F. Mei (Ancona (AN), Italy), A. De Lauretis (Garbagnate Milanse (MI), Italy), D. Visca (Tradate (VA), Italy), N. Goh (Melburne, Australia), M. Bonini (Rome (RM), Italy), C. La Vecchia (Milan (MI), Italy), F. Chua (London, United Kingdom), V. Kouranos (London, United Kingdom), G. Margaritopoulos (manchester, United Kingdom), M. Kokosi (London, United Kingdom), T. Maher (London, United Kingdom), S. Gasparini (Ancona (AN) , Italy), A. Gabrielli (Ancona (AN), Italy), A. Wells (London , United Kingdom), E. Renzoni (London, United Kingdom). Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact. 792

Member's Comments

No comment yet.

Related content which might interest you: Survival and prognostic factors in progressive systemic sclerosis with lung involvement Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 The significance of serum biomarkers as predictive factors for the clinical course of idiopathic pleuroparenchymal fibroelastosis (IPPFE) Source: International Congress 2017 – Rare diseases Year: 2017 Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013 Prognostic and clinical value of cluster analysis of idiopathic pleuroparenchymal fibroelastosis phenotypes Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 Histology is not a prognostic indicator in patients with interstitial pneumonias associated with systemic sclerosis Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001 Hemoptysis: rare pulmonary manifestation of tuberous sclerosis in childhood Source: Eur Respir J 2006; 28: Suppl. 50, 544s Year: 2006 The health status in idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017 Year: 2018 Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation Source: International Congress 2017 – PAH and CTEPH Year: 2017 Predicting factors for mortality in patients with pleuroparenchymal fibroelastosis Source: International Congress 2017 – Rare diseases Year: 2017 Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection? Source: Eur Respir J 2013; 41: 243-245 Year: 2013 Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes Source: Eur Respir J 2012; 40: 377-385 Year: 2012 Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity? Source: Eur Respir J 2015; 45: 1183-1186 Year: 2015 Idiopathic pulmonary fibrosis: classification, epidemiology, course and prognosis Source: International Congress 2016 – Russia Session Year: 2016 Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Clinical and laboratory features of systemic sclerosis with pulmonary involvement Source: Eur Respir J 2001; 18: Suppl. 33, 512s Year: 2001 Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis Source: Eur Respir J, 54 (2) 1900586; 10.1183/13993003.00586-2019 Year: 2019 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011 Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Source: Eur Respir J 2013; 42: 888-890 Year: 2013 Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases Source: Eur Respir J 2010; 35: 112-117 Year: 2010